| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |